Self-Assessment Program for JCMS Volume 23, Supplement 4

An accredited, online self-assessment program is now available for the September/October 2019 Supplement of the Journal of Cutaneous Medicine and Surgery.

The program was developed to assist dermatologists identify perceived and unperceived knowledge gaps relating to the safety and efficacy of topical calcineurin inhibitors and their applicability in the treatment of inflammatory skin diseases.

Each article is a designated module of the program and provides up to 0.5 hour of Section 3 Royal College Maintenance of Certification Program credits on completion, for a maximum of up to 2 hours.

To participate, read all articles of interest and complete the corresponding assessment. Assessment questions are multiple-choice and provide in-depth answers after each response. On completion of each module, the CDA will email you your certificate of participation, your answer score sheet and the answer key should you wish to consider a personal learning project.

Please take a few minutes to complete the post activity evaluation form at the bottom of this webpage. Your input will be helpful in confirming future educational initiatives.

Note: CDA members, as part of your membership, all articles are available online in full when logged in.

Member Login

Self-Assessment Program for JCMS Volume 23, Supplement 4

An accredited, online self-assessment program is now available for the September/October 2019 Supplement of the Journal of Cutaneous Medicine and Surgery.

The program was developed to assist dermatologists identify perceived and unperceived knowledge gaps relating to the safety and efficacy of topical calcineurin inhibitors and their applicability in the treatment of inflammatory skin diseases.

Each article is a designated module of the program and provides up to 0.5 hour of Section 3 Royal College Maintenance of Certification Program credits on completion, for a maximum of up to 2 hours.

To participate, read all articles of interest and complete the corresponding assessment. Assessment questions are multiple-choice and provide in-depth answers after each response. On completion of each module, the CDA will email you your certificate of participation, your answer score sheet and the answer key should you wish to consider a personal learning project.

Please take a few minutes to complete the post activity evaluation form at the bottom of this webpage. Your input will be helpful in confirming future educational initiatives.

Note: CDA members, as part of your membership, all articles are available online in full when logged in.

Member Login

Modules

Evidence review of topical calcineurin inhibitors for the treatment of adult atopic dermatitis

Learning Objectives

At the end of this module, participants will be able to:

  • Identify the role of TCIs in the management of adults with AD.
  • Describe the evidence that supports the use of TCIs as a class for the management of adult AD.
ArticleSelf-assessment

Contemporary role of topical calcineurin inhibitors: A pediatric dermatology perspective

Learning Objectives

At the end of this module, participants will be able to:

  • Identify the patients and conditions most likely to benefit from TCIs.
  • Describe the evidence that supports the use of TCIs in infant and pediatric patients.
ArticleSelf-assessment

What is the risk of harm associated with Topical Calcineurin Inhibitors?

Learning Objectives

At the end of this module, participants will be able to:

  • Identify the most common side effects and adverse events associated with the use of TCIs and provide timely references when discussing real-life risks and safety of TCIs with their patients.
  • Describe the safety and tolerability data that supports the use of TCIs in the treatment of AD both in pediatric and adult populations.
ArticleSelf-assessment

Off-label use of topical calcineurin inhibitors in dermatologic disorders

Learning Objectives

At the end of this module, participants will be able to:

  • Identify high-quality evidence that supports the use of TCIs in non-AD dermatologic indications.
  • Describe the efficacy data found in literature to support the use of TCIs in non-AD dermatologic conditions.
ArticleSelf-assessment
Evaluation Form

Accreditation Statement

This program is an Accredited Self-Assessment Program (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, and approved by Canadian Dermatology Association. You may claim a maximum of 2 hours (credits are automatically calculated).

This program was co-developed with LEO Pharma Canada and was planned to achieve scientific integrity, objectivity and balance.